ESR1 and breast cancer: To explore the mechanism underlying the synergistic effects of anti-estrogens and RAD001 on growth, we pre-treated ER+ breast cancer cells +/− fulv for 24 h (to allow time for ER transcriptional effects to subside), and then co-treated +/− RAD001 for 1 h or 24 h.